ArticleSocial psychiatry and psychiatric epidemiology2026
Global, regional, and national burdens of anxiety disorders among older adults, 1990-2021: A systematic analysis for the Global Burden of Diseases Study 2021.
Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association between psychological wellbeing and the COVID-19-related outcomes in Europeans aged ≥ 50 years old: The SHARE study.Human vaccines & immunotherapeutics · 2026Article
- Current Clinical Trials to Treat Anxiety Disorders in the Elderly: A Registry-Based Review.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
purposeTo assess the burden of anxiety disorders in the elderly and temporal trends at global, regional, and national levels during 1990-2021.
methodsData on incidence, prevalence, and disability-adjusted life years (DALYs) of anxiety disorders in the elderly over 60 years old were extracted from the Global Burden of Disease Study 2021. Average annual percentage changes were determined to analyze the trends in age-standardized rates between 1990 and 2021. Correlation between age-standardized rates and Socio-demographic Index (SDI) was assessed using Spearman's rank-correlation analysis. We used a meta-regression model to estimate the incidence, prevalence, and DALY rates before and during the COVID-19 pandemic.
resultsIn 2021, 4.49 million incident cases, 53.07 million prevalent cases, and 5.83 million DALYs were estimated in the elderly worldwide. The age-standardized incidence rate of anxiety disorders in older adults increased slightly, while prevalence and DALY rates remained stable. Middle SDI regions had the highest number of incident cases, prevalent cases, and DALYs, with the highest age-standardized prevalence and DALY rates in high SDI regions. Age-standardized prevalence and DALY rates of anxiety disorders were higher among elderly women than men. During the COVID-19 pandemic, the incidence rate of anxiety disorders among older adults rose by 7.82%, while prevalence and DALY rates increased by approximately 6%.
conclusionOver the past three decades, the increasing burden of anxiety disorders among older adults has significantly added to the global mental health challenges. This burden is intensified by socioeconomic factors, especially in middle SDI regions, and exacerbated by the COVID-19 pandemic.
Indexed as
Identifiers
41514081What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.